Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
Identifieur interne : 003F71 ( Main/Exploration ); précédent : 003F70; suivant : 003F72Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
Auteurs : Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-10.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Adulte.
English descriptors
- KwdEn :
- Activities of Daily Living, Adjuvant treatment, Adult, Advanced stage, Aged, Antiparkinson Agents (therapeutic use), Benzothiazoles, Bromocriptine, Bromocriptine (therapeutic use), Chemotherapy, Comparative study, Demography, Dose-Response Relationship, Drug, Double blind study, Double-Blind Method, Drug Administration Schedule, Drug Tolerance, Female, Humans, Levodopa, Male, Middle Aged, Multicenter study, Parkinson Disease (drug therapy), Parkinson disease, Parkinson's disease, Pramipexole, Prognosis, Prospective Studies, Quality of Life, Randomization, Thiazoles (therapeutic use), Time Factors, Treatment Outcome, bromocriptine, drug comparison, levodopa, pramipexole, randomized controlled trial (RCT).
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Bromocriptine, Thiazoles.
- drug therapy : Parkinson Disease.
- Activities of Daily Living, Aged, Benzothiazoles, Demography, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Drug Tolerance, Female, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Time Factors, Treatment Outcome.
Abstract
We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10508
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002090
- to stream Istex, to step Curation: 002090
- to stream Istex, to step Checkpoint: 002901
- to stream PubMed, to step Corpus: 003667
- to stream PubMed, to step Curation: 003667
- to stream PubMed, to step Checkpoint: 003663
- to stream Ncbi, to step Merge: 000B97
- to stream Ncbi, to step Curation: 000B97
- to stream Ncbi, to step Checkpoint: 000B97
- to stream Main, to step Merge: 005B94
- to stream PascalFrancis, to step Corpus: 002366
- to stream PascalFrancis, to step Curation: 000955
- to stream PascalFrancis, to step Checkpoint: 002344
- to stream Main, to step Merge: 005E90
- to stream Main, to step Curation: 003F71
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease</title><author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name></author><author><name sortKey="Yanagisawa, Nobuo" sort="Yanagisawa, Nobuo" uniqKey="Yanagisawa N" first="Nobuo" last="Yanagisawa">Nobuo Yanagisawa</name></author><author><name sortKey="Kuno, Sadako" sort="Kuno, Sadako" uniqKey="Kuno S" first="Sadako" last="Kuno">Sadako Kuno</name></author><author><name sortKey="Yamamoto, Mitsutoshi" sort="Yamamoto, Mitsutoshi" uniqKey="Yamamoto M" first="Mitsutoshi" last="Yamamoto">Mitsutoshi Yamamoto</name></author><author><name sortKey="Hasegawa, Kazuko" sort="Hasegawa, Kazuko" uniqKey="Hasegawa K" first="Kazuko" last="Hasegawa">Kazuko Hasegawa</name></author><author><name sortKey="Origasa, Hideki" sort="Origasa, Hideki" uniqKey="Origasa H" first="Hideki" last="Origasa">Hideki Origasa</name></author><author><name sortKey="Kowa, Hisayuki" sort="Kowa, Hisayuki" uniqKey="Kowa H" first="Hisayuki" last="Kowa">Hisayuki Kowa</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:208FBEE8530BCEF13B6623F482C832708DDB9348</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10508</idno><idno type="url">https://api.istex.fr/document/208FBEE8530BCEF13B6623F482C832708DDB9348/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002090</idno><idno type="wicri:Area/Istex/Curation">002090</idno><idno type="wicri:Area/Istex/Checkpoint">002901</idno><idno type="wicri:doubleKey">0885-3185:2003:Mizuno Y:randomized:double:blind</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:14534919</idno><idno type="wicri:Area/PubMed/Corpus">003667</idno><idno type="wicri:Area/PubMed/Curation">003667</idno><idno type="wicri:Area/PubMed/Checkpoint">003663</idno><idno type="wicri:Area/Ncbi/Merge">000B97</idno><idno type="wicri:Area/Ncbi/Curation">000B97</idno><idno type="wicri:Area/Ncbi/Checkpoint">000B97</idno><idno type="wicri:doubleKey">0885-3185:2003:Mizuno Y:randomized:double:blind</idno><idno type="wicri:Area/Main/Merge">005B94</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:04-0095349</idno><idno type="wicri:Area/PascalFrancis/Corpus">002366</idno><idno type="wicri:Area/PascalFrancis/Curation">000955</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002344</idno><idno type="wicri:doubleKey">0885-3185:2003:Mizuno Y:randomized:double:blind</idno><idno type="wicri:Area/Main/Merge">005E90</idno><idno type="wicri:Area/Main/Curation">003F71</idno><idno type="wicri:Area/Main/Exploration">003F71</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease</title><author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Yanagisawa, Nobuo" sort="Yanagisawa, Nobuo" uniqKey="Yanagisawa N" first="Nobuo" last="Yanagisawa">Nobuo Yanagisawa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Kanto Rosai Hospital, Kawasaki</wicri:regionArea><wicri:noRegion>Kawasaki</wicri:noRegion></affiliation></author><author><name sortKey="Kuno, Sadako" sort="Kuno, Sadako" uniqKey="Kuno S" first="Sadako" last="Kuno">Sadako Kuno</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Center for Neurological disease, Clinical Research Section, Utano National Hospital, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Yamamoto, Mitsutoshi" sort="Yamamoto, Mitsutoshi" uniqKey="Yamamoto M" first="Mitsutoshi" last="Yamamoto">Mitsutoshi Yamamoto</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Kagawa Prefectural Central Hospital, Takamatsu</wicri:regionArea><wicri:noRegion>Takamatsu</wicri:noRegion></affiliation></author><author><name sortKey="Hasegawa, Kazuko" sort="Hasegawa, Kazuko" uniqKey="Hasegawa K" first="Kazuko" last="Hasegawa">Kazuko Hasegawa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Sagamihara National Hospital, Sagamihara</wicri:regionArea><wicri:noRegion>Sagamihara</wicri:noRegion></affiliation></author><author><name sortKey="Origasa, Hideki" sort="Origasa, Hideki" uniqKey="Origasa H" first="Hideki" last="Origasa">Hideki Origasa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Biostatistics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama</wicri:regionArea><wicri:noRegion>Toyama</wicri:noRegion></affiliation></author><author><name sortKey="Kowa, Hisayuki" sort="Kowa, Hisayuki" uniqKey="Kowa H" first="Hisayuki" last="Kowa">Hisayuki Kowa</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Kitasato University, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-10">2003-10</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1149">1149</biblScope><biblScope unit="page" to="1156">1156</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">208FBEE8530BCEF13B6623F482C832708DDB9348</idno><idno type="DOI">10.1002/mds.10508</idno><idno type="ArticleID">MDS10508</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activities of Daily Living</term><term>Adjuvant treatment</term><term>Adult</term><term>Advanced stage</term><term>Aged</term><term>Antiparkinson Agents (therapeutic use)</term><term>Benzothiazoles</term><term>Bromocriptine</term><term>Bromocriptine (therapeutic use)</term><term>Chemotherapy</term><term>Comparative study</term><term>Demography</term><term>Dose-Response Relationship, Drug</term><term>Double blind study</term><term>Double-Blind Method</term><term>Drug Administration Schedule</term><term>Drug Tolerance</term><term>Female</term><term>Humans</term><term>Levodopa</term><term>Male</term><term>Middle Aged</term><term>Multicenter study</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Pramipexole</term><term>Prognosis</term><term>Prospective Studies</term><term>Quality of Life</term><term>Randomization</term><term>Thiazoles (therapeutic use)</term><term>Time Factors</term><term>Treatment Outcome</term><term>bromocriptine</term><term>drug comparison</term><term>levodopa</term><term>pramipexole</term><term>randomized controlled trial (RCT)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Bromocriptine</term><term>Thiazoles</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Activities of Daily Living</term><term>Aged</term><term>Benzothiazoles</term><term>Demography</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Drug Administration Schedule</term><term>Drug Tolerance</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Quality of Life</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term><term>Bromocriptine</term><term>Chimiothérapie</term><term>Etude comparative</term><term>Etude double insu</term><term>Etude multicentrique</term><term>Lévodopa</term><term>Parkinson maladie</term><term>Pramipexole</term><term>Pronostic</term><term>Randomisation</term><term>Stade avancé</term><term>Traitement adjuvant</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment. © 2003 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Japon</li></country><settlement><li>Tokyo</li></settlement></list><tree><country name="Japon"><noRegion><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name></noRegion><name sortKey="Hasegawa, Kazuko" sort="Hasegawa, Kazuko" uniqKey="Hasegawa K" first="Kazuko" last="Hasegawa">Kazuko Hasegawa</name><name sortKey="Kowa, Hisayuki" sort="Kowa, Hisayuki" uniqKey="Kowa H" first="Hisayuki" last="Kowa">Hisayuki Kowa</name><name sortKey="Kuno, Sadako" sort="Kuno, Sadako" uniqKey="Kuno S" first="Sadako" last="Kuno">Sadako Kuno</name><name sortKey="Origasa, Hideki" sort="Origasa, Hideki" uniqKey="Origasa H" first="Hideki" last="Origasa">Hideki Origasa</name><name sortKey="Yamamoto, Mitsutoshi" sort="Yamamoto, Mitsutoshi" uniqKey="Yamamoto M" first="Mitsutoshi" last="Yamamoto">Mitsutoshi Yamamoto</name><name sortKey="Yanagisawa, Nobuo" sort="Yanagisawa, Nobuo" uniqKey="Yanagisawa N" first="Nobuo" last="Yanagisawa">Nobuo Yanagisawa</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F71 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F71 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:208FBEE8530BCEF13B6623F482C832708DDB9348
|texte= Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |